Trial intelligence / Profile preview

Intrathecal Dexmedetomidine Versus TAP Block for Post-Cesarean Analgesia

NCT04969705Completed

Sponsor
Sohag University
Start
Jan 2022
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Sohag University. Primary endpoint: Analgesic efficacy of both routes at 24 hours. Started Jan 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04969705.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04969705.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call